Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rutgers, The State University of New Jersey
With
Colorado Department of Public Health and Environment
University of New Mexico
There is increasing evidence that activated and engaged patients who are equipped with necessary skills and information are more likely to follow through with recommended care and have better health outcomes at reduced costs. Identification of individuals at increased risk of hereditary breast and ovarian cancer (HBOC) is crucial for cancer survivors and their families to benefit from biomedical advances in cancer prevention, early detection, treatment and survivorship. The primary purpose of this study is to assess the feasibility and acceptability of two remote interventions aimed at promoting cancer genetic risk assessment (CGRA) for HBOC. The randomized controlled trial will have 3 arms: usual care (UC) vs. targeted generic print (TP) vs. tailored telephone counseling and navigation intervention (TCN).
Age
21–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Breast Cancer
Hispanic or non-Hispanic
Female
21 years of age or older
English-speaking
Breast cancer history
* breast cancer at the age of 50 or younger OR
* triple-negative breast cancer OR
* two or more primary breast cancers
Ovarian Cancer
Hispanic or non-Hispanic
Female
21 years of age or older
English-speaking
History of ovarian, fallopian, or peritoneal cancer diagnosed at any age
You may not be if
Have had prior genetic counseling or testing for hereditary breast and/or ovarian cancer